Aurinia Pharmaceuticals Inc. (AUPH) Total liabilities 2019–2025
Aurinia Pharmaceuticals Inc. (AUPH) total liabilities at each fiscal year-end, per SEC filings.
$170.3MFY2025 · since FY2019: $25.7M → $170.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $170.3M | -1.7% |
| FY2024 | $173.2M | +1.8% |
| FY2023 | $170.1M | +160.0% |
| FY2022 | $65.4M | +1.8% |
| FY2021 | $64.3M | +15.0% |
| FY2020 | $55.9M | +117.5% |
| FY2019 | $25.7M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice